Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Craddock

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Cambridge Prisms. Precision Medicine|February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunitiesCharles Craddock, Philip Earwaker, Matthew Fittall, et al.
Cancer Cell|January 22, 2011
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemiaNicolas Goardon, Emanuele Marchi, Ann Atzberger, et al.
The Journal of Experimental Medicine|July 6, 2016
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stageLynn Quek, Georg W Otto, Catherine Garnett, et al.
Bone Marrow Transplantation|November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.
British Journal of Haematology|June 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromesJustin Loke, Vinit Upasani, Charlotte Gaskell, et al.
Bone Marrow Transplantation|January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation|March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Leukemia|August 9, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Nicola Potter, Katya Mokretar, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Cambridge Prisms. Precision Medicine|February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunitiesCharles Craddock, Philip Earwaker, Matthew Fittall, et al.
Cancer Cell|January 22, 2011
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemiaNicolas Goardon, Emanuele Marchi, Ann Atzberger, et al.
The Journal of Experimental Medicine|July 6, 2016
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stageLynn Quek, Georg W Otto, Catherine Garnett, et al.
Bone Marrow Transplantation|November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.
British Journal of Haematology|June 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromesJustin Loke, Vinit Upasani, Charlotte Gaskell, et al.
Bone Marrow Transplantation|January 31, 2020
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Bone Marrow Transplantation|March 8, 2020
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Myriam Labopin, Bipin N Savani, et al.
Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Blood|January 15, 2020
Molecular MRD status and outcome after transplantation in NPM1-mutated AMLRichard Dillon, Robert Hills, Sylvie Freeman, et al.
Leukemia|August 9, 2023
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AMLJad Othman, Nicola Potter, Katya Mokretar, et al.
Pageof 17